AC-P19M

General Information


DCTPep ID  DCTPep04527

Peptide Name   AC-P19M

Sequence  FAKKLAKLKKKLAKLAKKR

Sequence Length  19

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Cancer therapy related peptides



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available



Structure Information


PDB ID  Not available

Predicted Structure  Not available

(Please note that there is the predicted structure, predicted by AlphaFold)

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C105H195N31O20

Absent amino acids  CDEGHIMNPQSTVWY

Theoretical pI  11.53

Acidic residues  0

Basic residues  10

Polar residues  0

Molecular weight (Average)  2211.9

Molecular weight (Monoisotopic)  2210.52

Common amino acids  K

Net charge  10

Instability index (II)  4.29

Aliphatic index  103.16

Grand average of hydropathicity (GRAVY)  -0.758

Half Life 
  1.1 hours (mammalian reticulocytes, in vitro).
  3 min (yeast, in vivo).
  2 min (Escherichia coli, in vivo).

Extinction coefficients 
  Should not be visible by UV spectrophotometry.

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 36555235

Title  De Novo Design of AC-P19M, a Novel Anticancer Peptide with Apoptotic Effects on Lung Cancer Cells and Anti-Angiogenic Activity

Doi 10.3390/ijms232415594

Year  2022

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  20465

DCTPep is developed by Dr.Zheng's team.